Baxter International

Baxter International ROA

The Return on Assets (ROA) of Baxter International (BAX) as of Nov 5, 2026 is -4.77 %. In the previous year, Return on Assets (ROA) was -2.52 % — a change of 89.57% (lower).

ROA

-4.77 %

YoY

89.57%

Last updated:

In 2025, Baxter International's return on assets (ROA) was -4.77 %, a 89.57% increase from the -2.52 % ROA in the previous year.

The Baxter International ROA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROA
Date
ROA
Jan 1, 2018
9.83 USD
Jan 1, 2019
5.50 USD
Jan 1, 2020
5.50 USD
Jan 1, 2021
3.83 USD
Jan 1, 2022
-8.60 USD
Jan 1, 2023
9.39 USD
Jan 1, 2024
-2.52 USD
Jan 1, 2025
-4.77 USD
The Baxter International ROA history
YEARROAYoY
-4.77 %+89.57%
-2.52 %-126.80%
9.39 %-209.21%
-8.60 %-324.55%
3.83 %-30.42%
5.50 %+0.05%
5.50 %-44.05%
9.83 %+179.53%
3.52 %-88.98%
31.94 %+591.60%
4.62 %-51.66%
9.55 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Baxter International Stock analysis

What does Baxter International do? Baxter International Inc is a global company specialized in the development, manufacturing, and marketing of medical therapy products to improve the lives of patients worldwide. It was originally founded in 1931 as the American Hospital Supply Corporation. Since then, the company has continuously evolved and is now a leading provider of medical products and services. The company's history began in 1931 with the founding of the American Hospital Supply Corporation in Illinois. Over the years, the company acquired several small companies and expanded its range of medical products and services. In 1985, the company changed its name to Baxter Travenol Laboratories, Inc. and merged with Travenol Laboratories, Inc. Finally, in 1995, it was renamed Baxter International Inc. to reflect the international focus of the company. Baxter International Inc can be considered as a manufacturer and supplier of medical products in various areas of healthcare. The company is divided into several divisions to better structure and organize its different product and service offerings. The main divisions of the company are infusion systems and devices, parenteral nutrition, renal care products, biopharmaceuticals, and drug delivery systems and bottles. The infusion systems and devices division represents the largest share of Baxter International Inc's revenue. This division is involved in the manufacturing and marketing of products such as infusion pumps and tubing systems, which allow the precise and controlled delivery of fluids and medications into a patient's body. Another important area of Baxter International Inc is the manufacturing of parenteral nutrition. This involves the production of complex nutrient mixtures that are directly injected into the patient's vein when they are unable to receive nutrients in other ways. The company offers a variety of parenteral nutrition solutions enriched with carbohydrates, amino acids, and fats. The renal care products division of Baxter International is specialized in the development and manufacturing of devices and materials necessary for dialysis. Baxter International offers a wide range of dialysis machines and solutions that can be used in the treatment of patients with kidney problems. The company has also developed an extensive range of pediatric devices and solutions to meet the needs of children and adults. The biopharmaceuticals division of Baxter International Inc. focuses on the development and production of innovative medications. The company has a particular focus on the treatment of diseases such as hemophilia and immune disorders. Baxter International Inc. also distributes therapies that can be used to treat various diseases such as cancer or neurological disorders. The drug delivery systems and bottles division is responsible for the manufacturing of accessories, including bottles, bags, and connectors. The company develops and produces a variety of products focusing on drug administration, such as specialized bottles and syringes. Baxter International Inc. offers a wide range of products aimed at improving the health and lives of patients. In addition to infusion pumps and parenteral nutrition, the company also provides wound care devices, blood donation systems, vaccines, and much more. Product development is always tailored to the needs of end-users to ensure the highest possible quality of products and services. In conclusion, Baxter International Inc has established itself as a leading company in the medical and healthcare industry. The expansion of its product range, international focus, and emphasis on meeting the needs of end-users have contributed to the company's continuous growth and success. Furthermore, the company has made a significant contribution to improving healthcare worldwide through its products and services. Baxter International is one of the most popular companies on Eulerpool.

ROA Details

Understanding Baxter International's Return on Assets (ROA)

Baxter International's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Baxter International's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Baxter International's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Baxter International’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Baxter International stock

Return on Assets (ROA) of Baxter International is -4.77 % in 2025.

Return on Assets (ROA) of Baxter International changed from -2.52 % to -4.77 %, representing a 89.57% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Return on Assets (ROA) Baxter International since 2006 – with annual values, charts, and detailed analysis.

Return on Assets, also known as ROA, is a financial metric used to measure a company's profitability. It is used to determine how effectively a company uses its assets to generate profits. It is also referred to as the ratio of net income to total assets. ROA is an important indicator of a company's overall financial performance as it measures the company's ability to generate more profit from the assets it employs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Assets (ROA)'s Baxter International with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Assets (ROA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Assets (ROA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Baxter International

All Key Metrics — Baxter International